Twist Bioscience Corporation has released a corporate presentation detailing its strategic operations and financial performance. The presentation highlights the company's innovative approach to DNA and protein markets, emphasizing the scalability of its DNA on Silicon Platform. Twist Bioscience also outlines plans for product expansion and market growth across various applications. The company continues to focus on increasing its customer base and enhancing its competitive position in the synthetic biology sector. You can access the full presentation through the link below.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。